Why Usana Health Sciences Stock Plummeted This Week
Usana's second-quarter report arrived with some worrying news for investors.
Overview
Usana Health Sciences (NYSE: USNA) stock saw a huge valuation contraction this week in response to disappointing second-quarter results. The company's share price declined 30% across the stretch. Meanwhile, the S&P 500 rose 3.6%, and the Nasdaq Composite gained 5.2%.
Usana published its second quarter results on Aug. 4, and both sales and earnings for the period came in significantly worse than the average analyst estimates. In addition to the weak Q2 print, the company also issued new forward guidance that disappointed the market.
Image source: Getty Images.
Details
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.